Original Articles

Health-Related Quality of Life among Iranian Women With Uterine Fibroids: A Cross Sectional Study

Abstract

Objective: Uterine fibroids (UFs) are the most common benign tumors in women, and their prevalence varies between 5.4 and 77.0% in reproductive-aged women. Patients with UFs may experience severe symptoms that they can affect different aspects of their lives, including quality of life. This study aimed to investigate the health-related quality of life among Iranian women with UFs.
Materials and methods: This cross-sectional study was conducted at Imam Hossein Hospital, Tehran, Iran, between November 2023 and February 2024, Data collection was based on the census method. Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) questionnaire was used to assess symptom severity and health-related quality of life (HRQOL) of women with UFs. Data were analyzed using the SPSS software version 23.0.
Results: Overall, 220 patients with a mean age of 43.10±5.01 years were included in the study. Patients had total UFS-QOL score of 64.11±20.35 with the following subscales’ scores: symptom severity: (19.00±6.39), concern: (60.79±26.47), activities: (71.76±23.02), energy/mood: (54.39±25.14), control: (66.52±22.82), self-consciousness: (77.63±26.39), and sexual function: (59.40±31.18). Furthermore, patients with multiparity history (P= 0.001), obesity (P<0.001), increased menstrual duration (P<0.001), irregular menstruation (P<0.001), and hyper menorrhea (P<0.001) had lower HRQOL scores.
Conclusion: All subscales’ scores of HRQOL were over 50 in patients with UF. HRQOL in these patients can be affected by certain factors, such as features of the menstrual cycle, multiparity, and obesity.

 

1. Hervé F, Katty A, Isabelle Q, Céline S. Impact of uterine fibroids on quality of life: a national
cross-sectional survey. Eur J Obstet Gynecol Reprod Biol. 2018;229:32-7.
2. Ahmad A, Kumar M, Bhoi NR, Badruddeen, Akhtar J, Khan MI, et al. Diagnosis and management of uterine fibroids: current trends and future strategies. J Basic Clin Physiol Pharmacol. 2023;34(3):291-310.
3. Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022;43(4):678-719.
4. Millien C, Manzi A, Katz AM, Gilbert H, Smith Fawzi MC, Farmer PE, et al. Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study. Int J Equity Health. 2021;20(1):1.
5. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3-9.
6. Luthra J, Halder P, Nahar L, Sultana N, Banerjee A, Kumar A, et al. Evaluation of psychometric properties of the uterine fibroids symptoms and health-related quality of life (ufsqol) questionnaire: The translated Bengali version. Trop J Obstet Gynaecol. 2019;36(3):338-47.
7. Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):96-102.
8. Najafiarab H, Keyvanfar A, Rahimi Mansour F, Didar H, Hooshmand Chayijan SH, Rajaei Firouzabadi SH, et al. Validity and Reliability of The Persian Version of Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire: A Psychometric Study. Int J Fertil Steril. 2023;18(1):60-6.
9. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290-300.
10. Koga K, Fukui M, Fujisawa M, Suzukamo Y. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey). Journal of Obstetrics and Gynaecology Research. 2023;49(10):2528-37.
11. Hunsche E, Rakov V, Scippa K, Witherspoon B, McKain L. The Burden of Uterine Fibroids from the
Perspective of US Women Participating in Open-Ended Interviews. Womens Health Rep (New Rochelle). 2022;3(1):286-96.
12. Abdelmtalab MA, Tahir O, Hussein K, Badawi K. Anatomical locations of uterine fibroids in Sudanese women. Anatomy Journal of Africa. 2020;9(1):1701-6.
13. Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181-91.
14. Shimamoto K, Hirano M, Wada-Hiraike O, Goto R, Osuga Y. Examining the association between menstrual symptoms and health-related quality of life among working women in Japan using the EQ-5D. BMC Womens Health. 2021;21(1):325.
15. Soliman AM, Margolis MK, Castelli-Haley J, Fuldeore MJ, Owens CD, Coyne KS. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Curr Med Res Opin. 2017;33(11):1971-8.
16. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC women's health. 2012;12:1-11.
17. Brito LG, Panobianco MS, Sabino-de-Freitas MM, Barbosa Hde F, de Azevedo GD, Brito LM, et al. Uterine leiomyoma: understanding the impact of symptoms on womens' lives. Reprod Health.
2014;11(1):10.
18. Adebimpe WO, Farinloye EO, Adeleke NA. Menstrual pattern and disorders and impact on quality of life among university students in South-Western Nigeria. Journal of Basic and Clinical Reproductive Sciences. 2016;5(1):27-32.
19. Ekin M, Cengiz H, Öztürk E, Kaya C, Yasar L, Savan K. Genitourinary symptoms and their effects on quality of life in women with uterine myomas. Int Urogynecol J. 2014;25(6):807-10.
20. Feng C, Meldrum S, Fiscella K. Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone. Int J Gynaecol Obstet. 2010;109(2):121-4.
21. Torng PL, Chang WC, Hwang JS, Hsu WC, Wang JD, Huang SC, et al. Health-related quality of life after laparoscopically assisted vaginal hysterectomy: is uterine weight a major factor? Qual Life Res. 2007;16(2):227-37.
Files
IssueVol 18, No 3 (September 2024) QRcode
SectionOriginal Articles
DOI https://doi.org/10.18502/jfrh.v18i3.16658
Keywords
Leiomyoma Quality of Life Uterine Fibroid Symptom and Health-Related Quality of Life Menstrual Cycle
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Najafiarab H, Farzaneh F, Talebian N, Ghasemi Z, Talayeh M. Health-Related Quality of Life among Iranian Women With Uterine Fibroids: A Cross Sectional Study. J Family Reprod Health. 2024;18(3):164-169.